Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)
CUSIP: 92511W108
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 92,448,158
- Total 13F shares
- 10,821,432
- Share change
- -536,136
- Total reported value
- $29,758,148
- Put/Call ratio
- 14%
- Price per share
- $2.75
- Number of holders
- 49
- Value change
- -$1,572,823
- Number of buys
- 24
- Number of sells
- 22
Quarterly Holders Quick Answers
What is CUSIP 92511W108?
CUSIP 92511W108 identifies VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92511W108:
Top shareholders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
5.5%
|
5,038,983
|
$14,714,000 | — | 30 Sep 2022 | |
| FMR LLC |
13F
|
Company |
1.7%
|
1,598,055
|
$4,666,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
1,012,596
|
$2,956,000 | — | 30 Sep 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.53%
|
485,802
|
$1,419,000 | — | 30 Sep 2022 | |
| Fosun International Ltd |
13F
|
Company |
0.31%
|
282,408
|
$825,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.3%
|
279,243
|
$816,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.25%
|
230,300
|
$672,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
150,235
|
$438,000 | — | 30 Sep 2022 | |
| SteelPeak Wealth, LLC |
13F
|
Company |
0.15%
|
134,661
|
$393,000 | — | 30 Sep 2022 | |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
|
Company |
0.14%
|
129,251
|
$377,000 | — | 30 Sep 2022 | |
| Composition Wealth, LLC |
13F
|
Company |
0.14%
|
125,000
|
$365,000 | — | 30 Sep 2022 | |
| MML INVESTORS SERVICES, LLC |
13F
|
Company |
0.1%
|
89,950
|
$263,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.08%
|
74,074
|
$216,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.08%
|
73,454
|
$215,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.07%
|
62,816
|
$183,000 | — | 30 Sep 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.05%
|
48,893
|
$143,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
48,146
|
$141,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
42,217
|
$123,000 | — | 30 Sep 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
35,001
|
$102,000 | — | 30 Sep 2022 | |
| BECK MACK & OLIVER LLC |
13F
|
Company |
0.03%
|
30,000
|
$88,000 | — | 30 Sep 2022 | |
| A. Brian Davis |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
12,900
|
$83,721 | — | 04 Jun 2021 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.03%
|
28,000
|
$82,000 | — | 30 Sep 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
24,550
|
$72,000 | — | 30 Sep 2022 | |
| LPL Financial LLC |
13F
|
Company |
0.02%
|
22,000
|
$64,000 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
19,714
|
$57,000 | — | 30 Sep 2022 | |
| OCCUDO QUANTITATIVE STRATEGIES LP |
13F
|
Company |
0.02%
|
17,755
|
$52,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
17,594
|
$51,000 | — | 30 Sep 2022 | |
| Creative Planning |
13F
|
Company |
0.02%
|
14,781
|
$43,000 | — | 30 Sep 2022 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.01%
|
13,400
|
$39,000 | — | 30 Sep 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.01%
|
12,600
|
$37,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
12,572
|
$37,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
11,563
|
$34,000 | — | 30 Sep 2022 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.01%
|
11,411
|
$33,000 | — | 30 Sep 2022 | |
| TRUIST FINANCIAL CORP |
13F
|
Company |
0.01%
|
11,298
|
$33,000 | — | 30 Sep 2022 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.01%
|
11,024
|
$32,000 | — | 30 Sep 2022 | |
| Virtu Financial LLC |
13F
|
Company |
0.01%
|
10,834
|
$32,000 | — | 30 Sep 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.01%
|
9,422
|
$28,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
7,045
|
$21,000 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
5,510
|
$16,000 | — | 30 Sep 2022 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
4,600
|
$13,000 | — | 30 Sep 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
2,841
|
$8,000 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
2,701
|
$8,000 | — | 30 Sep 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,500
|
$4,000 | — | 30 Sep 2022 | |
| Asset Dedication, LLC |
13F
|
Company |
0%
|
1,193
|
$3,000 | — | 30 Sep 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
510
|
$1,489 | — | 30 Sep 2022 | |
| BENJAMIN F. EDWARDS & COMPANY, INC. |
13F
|
Company |
0%
|
500
|
$1,000 | — | 30 Sep 2022 | |
| China Universal Asset Management Co., Ltd. |
13F
|
Company |
0%
|
385
|
$1,000 | — | 30 Sep 2022 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
301
|
$1,000 | — | 30 Sep 2022 |
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q4 2022
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.